# Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel

> **NCT03994406** · PHASE2 · COMPLETED · sponsor: **Glia, LLC** · enrollment: 30 (actual)

## Conditions studied

- Contact Lens Discomfort
- Contact Lens-induced Corneal Disorder
- Contact Lens Acute Red Eye
- Contact Lens-induced Corneal Fluorescein Staining

## Interventions

- **DRUG:** CLM2 topical gel
- **DRUG:** Placebo topical gel

## Key facts

- **NCT ID:** NCT03994406
- **Lead sponsor:** Glia, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-27
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-10-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03994406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03994406, "Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT03994406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*